Silibinin‐induced endoplasmic reticulum stress and mitochondrial dysfunction suppress growth of endometriotic lesions
Silibinin reduced endometriotic lesion growth in mice and human cells by inducing endoplasmic reticulum stress, mitochondrial dysfunction, and apoptosis via oxidative stress and increased calcium levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- Aromatase and endometriosis: estrogens play a role via openalex
- A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid via openalex
- Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis via openalex
- Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model via openalex
- Endometriosis after Menopause via openalex
- Endometriosis and Infertility via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriosis still a challenge. via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- <i>In Vitro</i> Fertilization for Endometriosis-Associated Infertility via openalex
- Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue via openalex
- Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
- Surgical treatment of deep endometriosis and risk of recurrence via openalex
- Surgical treatment of deep endometriosis and risk of recurrence via openalex
- W2011392636 via openalex
- W2023009163 via openalex
- W2044789167 via openalex
- W2055759954 via openalex
- W2076345963 via openalex
- W2085933321 via openalex
- W2097501793 via openalex
- W2100123437 via openalex
- W2101163417 via openalex
- W2104692302 via openalex
- W2136997516 via openalex
- W2138697213 via openalex
- W2164746176 via openalex
- W2165064047 via openalex
- W2469021220 via openalex
- W2473259496 via openalex
- W2734059867 via openalex
- W2767755407 via openalex
- W4211081176 via openalex
- W250772872 via openalex
- W6635732373 via openalex
- W358640895 via openalex
- W1165140024 via openalex
- W1495229822 via openalex
- W1498253116 via openalex
- W1676037321 via openalex
- W1781122666 via openalex
- W1922025862 via openalex
- W1953598538 via openalex
- W1963643075 via openalex
- W1979191248 via openalex
- W1992533338 via openalex
- W1996063478 via openalex
- W1998795042 via openalex
Cited by (13)
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Mitochondrial dynamics: Molecular mechanism and implications in endometriosis 2025
- Identified endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis 2025
- Mitochondrial Involvement in the Pathogenesis of Endometriosis and its Potential as Therapeutic Targets 2025
- AQbD-guided development of a green RP-HPLC method for dual drug quantification in lipid–polymer hybrid nanoparticles for endometriosis therapy 2025
- Bioinformatic analysis reveals endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis:implications for disease subtyping and therapeutic strategies 2024
- Endoplasmic reticulum stress of endometrial mesenchymal stem cells in endometriosis 2024
- The role of endoplasmic reticulum stress in endometriosis 2023
- A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations 2022
- Inhibitory Effects of 6,8-Diprenylorobol on Endometriosis Progression in Humans by Disrupting Calcium Homeostasis and Mitochondrial Function 2022
- Effect of silymarin on Interleukin-6 level and size of endometrioma lesions in women with ovarian endometriosis: a randomized, double-blind placebo-controlled trial 2022
- Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review 2021
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:37.156494+00:00